References
1. Ballreich JM, Gross CP, Powe NR, et al. Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019. JAMA Network Open 2021;4:e2034890-e2034890.
2. Kobayashi T, Hibi T. Improving IBD outcomes in the era of many treatment options. Nature Reviews Gastroenterology & Hepatology 2023;20:79-80.
3. Manns MP, Maasoumy B. Breakthroughs in hepatitis C research: from discovery to cure. Nature Reviews Gastroenterology & Hepatology 2022;19:533-550.
4. Ying X, Rosenblatt R, Fortune BE. Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States From 2014 to 2020. Gastroenterology 2022;163:787-791.
5. Murayama A, Kugo H, Saito Y, et al. A Nine-year Investigation of Healthcare Industry Payments to Pulmonologists in the United States. Ann Am Thorac Soc 2023.
6. Murayama A, Hirota S. Industry payments to pathologists in the USA between 2013 and 2021. J Clin Pathol 2023.
7. Murayama A, Kamamoto S, Kugo H, et al. Research and Non-research Industry Payments to Nephrologists in the United States between 2014 and 2021 (in press). Journal of the American Society of Nephrology 2023.
8. Vanood A, Sharrak A, Karabon P, et al. Industry-Sponsored Research Payments in Neurosurgery-Analysis of the Open Payments Database From 2014 to 2018. Neurosurgery 2021;88:E250-e258.
9. Sharrak A, Nguyen T, Karabon P. Industry Research Payments to Urologists: The First 5 Years of Open Payments Research Data. J Urol 2020;204:408-410.
10. Kalva P, Kakkilaya A, Mekala P, et al. Trends and Characteristics of Industry Payments for Ophthalmology Research From 2014 to 2020. JAMA Ophthalmol 2022;140:1105-9.
11. Murayama A, Kamamoto S, Kawashima M, et al. Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019. BMJ Open 2023;13:e068237.
12. Scher JU, Schett G. Key opinion leaders - a critical perspective. Nat Rev Rheumatol 2021;17:119-124.
13. Ahn R, Woodbridge A, Abraham A, et al. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. BMJ 2017;356:i6770.
Table 1. Industry-sponsored grand, direct research and associated research payments between 2014 and 2021